Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis-Reference-Cited by-同舟云学术

Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis

Published:2019-12-17 Issue:5 Volume:107 Page:1159-1169
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Hsu Yun‐Shiuan O.¹,Wu I‐Wen²,Chang Shang‐Hung³,Lee Cheng‐Chia¹,Tsai Chung‐Ying¹,Lin Chan‐Yu¹,Lin Wan‐Ting⁴,Huang Yu‐Tung⁴,Wu Chao‐Yi⁵,Kuo George¹,Hsiao Chih‐Yen⁶,Lin Hsing‐Lin⁷,Yang Chih‐Chao⁸,Yen Tzung‐Hai¹,Chen Yung‐Chang¹,Hung Cheng‐Chieh¹,Tian Ya‐Chong¹,Kuo Chang‐Fu⁹,Yang Chih‐Wei¹,Anderson Gerard F.¹⁰,Yang Huang‐Yu¹¹⁰

Affiliation:

1. Kidney Research Institute Nephrology Department Chang Gung Memorial Hospital College of Medicine Chang Gung University Taoyuan Taiwan

2. Nephrology Department Chang Gung Memorial Hospital Keelung Taiwan

3. Cardiovascular Department Chang Gung Memorial Hospital Taoyuan Taiwan

4. Center for Big Data Analytics and Statistics Chang Gung Memorial Hospital Taoyuan Taiwan

5. Division of Allergy, Asthma, and Rheumatology Department of Pediatrics Chang Gung Memorial Hospital Chang Gung University College of Medicine Taoyuan Taiwan

6. Division of Nephrology Department of Internal Medicine Ditmanson Medical Foundation Chia‐Yi Christian Hospital Chia‐Yi County Taiwan

7. Division of Critical Care Surgery Department of Critical Care Medicine Veterans General Hospital Kaohsiung Taiwan

8. Nephrology Department Chang Gung Memorial Hospital Kaohsiung Taiwan

9. Division of Rheumatology, Allergy, and Immunology Chang Gung Memorial Hospital Taoyuan Taiwan

10. Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1697

Reference45 articles.

1. J-Shaped Mortality Relationship for Uric Acid in CKD

2. Hyperuricemia as an Independent Risk Factor of Chronic Kidney Disease in Middle-Aged and Elderly Population

3. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort

4. No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study

5. Effect of Urate Lowering Therapy on Renal Disease Progression in Hyperuricemic Patients with Chronic Kidney Disease

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease;Medical Science Monitor;2024-05-01

2. A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease;Cells;2024-03-04

3. The Terminalia chebula Retz extract treats hyperuricemic nephropathy by inhibiting TLR4/MyD88/NF-κB axis;Journal of Ethnopharmacology;2024-03

4. Urate‐Lowering Drugs and Muscle Injury: A Systematic Review and Network Meta‐Analysis;The Journal of Clinical Pharmacology;2023-10-30

5. Renal herb formula protects against hyperuricemic nephropathy by inhibiting apoptosis and inflammation;Phytomedicine;2023-07